Biotech News

DE LA SOUL-LED “GOOD HEALTH SUMMIT” LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE

Lixte Biotechnology Holdings (LIXT)Lixte Biotechnology Holdings2026-01-21 13:00 ESTCompany update

LIXT (LIXT) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is lixt.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Lixte Biotechnology Holdings

PP2A Inhibition in Cancer LIXTE Biotechnology develops cancer therapies based on inhibition of protein phosphatase 2A. Its lead molecule is intended to sensitize tumors to chemotherapy and immunotherapy rather than function solely as a stand-alone cytotoxic drug. LB-100 LB-100 is a first-in-class clinical PP2A inhibitor that has shown...

Recent company news

LIXTLixte Biotechnology Holdings2026-08-19 12:30 EST

Stock data

Close: 7.21 USD
Market cap: 87.18M USD
Exchange: NASDAQ
Sector: Biopharma
Location: United States

DE LA SOUL-LED “GOOD HEALTH SUMMIT” LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE

Related news

NOMAD Achieves UL 9540 Certification for 1 MW Transportable Battery Energy Storage System

NOMAD POWER SOLUTIONS FILES 2026 SECOND QUARTER FORM 10-Q, PROVIDES BUSINESS UPDATE

Lixte Biotechnology Holdings

Recent company news

NOMAD Achieves UL 9540 Certification for 1 MW Transportable Battery Energy Storage System

NOMAD POWER SOLUTIONS FILES 2026 SECOND QUARTER FORM 10-Q, PROVIDES BUSINESS UPDATE

NOMAD Power Solutions Announces Options Trading Begins on Cboe Options Exchange

NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative

NOMAD Power Solutions Strengthens Subsidiary Executive Leadership

Stock data